NIH-funded research R01 grant

Understanding the role of specific immune cells in Type 1 Diabetes

Official title: Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes

Funded at University of Miami School of Medicine · NIH-11041467 · Data updated 2026-11-12

This study is looking at how certain immune cells called CD8 T cells attack the insulin-producing cells in people with Type 1 Diabetes, using samples from organ donors to learn more about how these cells behave and could help find new ways to treat the condition.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Miami School of Medicine
NIH-funded
Lab location1 site (Coral Gables, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2024
Award (this year)$460,500
NIH project number7R01AI092453-12
Project IDNIH-11041467 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals diagnosed with Type 1 Diabetes, particularly those experiencing early stages of the disease.

Less likely to help

Patients with Type 2 Diabetes or other forms of diabetes unrelated to autoimmune processes may not benefit from this research.

What this research studies

This research investigates how CD8 T cells contribute to the destruction of insulin-producing cells in individuals with Type 1 Diabetes (T1D). By analyzing samples from organ donors, the study aims to identify the characteristics and functions of these immune cells, which are believed to play a key role in the disease. The researchers will use advanced techniques to track and quantify these cells within the pancreas, providing insights into their behavior during the progression of T1D. This work could lead to a better understanding of the autoimmune processes involved in T1D and potential new therapeutic targets.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments or preventive strategies for individuals with Type 1 Diabetes.

How similar studies have gone: Previous research has shown promising results in understanding the role of immune cells in Type 1 Diabetes, indicating that this approach has potential for significant findings.

Where this research is happening

  • University of Miami School of Medicine
    Coral Gables, United States
    Active

Researchers

  • Principal investigator: Quesada Masachs, Estefania — University of Miami School of Medicine
  • Study coordinator: Quesada Masachs, Estefania

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.